Objective: The absence of neurobiological diagnostic markers of bipolar disorder (BD) leads to its frequent misdiagnosis as unipolar depression (UD). We investigated if changes in fractional anisotropy (FA) could help to differentiate BD from UD in the state of depression. Conclusion: This is one of very few studies directly showing differences in FA between BD and UD. Gray matter FA changes in prefrontal areas might be precursors for future prefrontal gray matter abnormalities in these disorders.
| INTRODUCTION
Differentiating unipolar depression (UD) and depressive episodes in bipolar disorder (BD) is one of the major challenges in psychiatric diagnostics due to the fact that most bipolar patients primarily present with depressive symptoms. Therefore, misdiagnoses are common in BD and lead to poor outcomes and higher health care costs, which may be avoided by appropriate pharmacological treatment. 1, 2 Diffusion tensor imaging (DTI) is a useful tool with which to study microstructural abnormalities, particularly in white matter tracts, which are likely relevant in the pathophysiology of both neurological and psychiatric disorders, as they point towards altered connectivity in the brain.
Fractional anisotropy (FA), which can be seen as a quantitative index of white matter coherence, 4 has become the most common DTI measure in psychiatric research. 5 The current belief is that high FA values represent highly organized and normally myelinated axon structure. Therefore, decreased FA can be interpreted as a loss of coherence in the main preferred diffusion direction. 4 The utility of DTI metrics in gray matter (GM) has been poorly investigated and its meaning is open to debate: reports of changes of FA in GM are rare, 6, 7 as it is primarily seen as a measure of white matter integrity. 4 Nonetheless, there is evidence that decreases in FA within GM structures could be a sign of functionally relevant neurodegeneration before other structural magnetic resonance imaging (MRI) changes are detected. 7 Other studies investigated FA in GM structure, demonstrating FA changes as a marker for brain compression 8 and traumatic brain injury. 9 In a rat model, excess gliosis in GM structures led to increased FA values in these areas. 10 In general, DTI measures in GM could be a potential precursor for future GM atrophy in early
Alzheimer's disease.
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There is a growing body of DTI studies in UD and BD patients, with, however, massive heterogeneities regarding DTI methods (e.g., tract-based statistics vs voxel-wise approaches), sample characteristics, and the application of regional restraints (e.g., whole-brain anal-
yses vs region of interest focus). A recent meta-analysis 12 compared
FA changes in UD patients, BD patients and healthy controls (HC), including both studies using voxel-based analysis (VBA) and those using tract-based spatial statistics (TBSS) approaches. Results suggest that the corpus callosum and the cingulum bundle, in particular, show significant abnormalities in both disorders.
However, to the best of our knowledge, only three studies are currently available comparing UD to BD directly. In a study with 18 UD, 20 BD, and 21 HC, no differences between the patient groups but reduced FA in callosal fibers for both UD and BD compared to HC were observed. 13 Reduced FA in the superior longitudinal fascicle was detected in BD compared to UD in a study comprising 15 UD, 16 BD, and 24 HC. 14 Finally, in a study including 15 UD, 15 BD, and 21 HC using predefined tracts of interest, decreased FA in BD compared to UD was reported in white matter fiber bundles connecting structures of the anterior limbic network. 15 While changes in FA both in UD and in BD were commonly reported in previous studies, the etiopathological meaning of these lesions remains unclear. It remains to be clarified whether these structural alterations occur after disease onset or whether they represent potential markers of genetic risk (endophenotype). Some studies suggest that the decrease in FA correlates with clinical markers such as the number of depressive episodes, time since onset of disease or severity of illness, [16] [17] [18] which would point towards an effect of disease on the brain.
However, other studies have indicated that there may be genetic influences on FA in these patients and groups at risk, which would suggest that FA reductions may be a trait and vulnerability marker of BD. 19, 20 Hence, the main aim of the present study was to examine FA differences between BD and UD in well-characterized patient samples with a sample size more than a double those of the presently available reports. To address differences in the regional foci investigated in previous DTI studies on affective disorders, we used a comparable Table 1 . No significant differences in frequencies of comorbid diagnoses were found between patient groups (see Table S2 for further details).
We verified the diagnoses with the structured clinical interview for DSM-IV. 25 All patients were experiencing a current major depressive episode. Patients with additional comorbid life-time diagnoses of any schizophrenic/schizoaffective disorders, substance-related disorders, organic mental disorders, or dementia were excluded from the study. We used an established strategy 26, 27 to measure the medication load: each psychopharmacologic medication was defined as absent = 0, low = 1 (equal or lower average dose), or high = 2 (greater than average dose). The average dose was defined by the midpoint of the daily dose range recommended by Physician's Desk. 28 By summing all medication scores, we created a measure that accounted for both the number and the dose of all current psychopharmacological medications taken by the patient. Number of maniac episodes 4.1 4.3 n/a n/a n/a
Lifetime cumulative duration of maniac episodes (months)
9.1 19.9 n/a n/a n/a We applied the Beck Depression Inventory (BDI; 28, 29 ) and the 
| Data preprocessing

| RESULTS
| White matter analysis
In the t contrast, UD patients showed decreased FA in the right cor- Figure 1 ). Table 2 and Figure 2 . We did not find any group differences in the uncinate fascicle. Figure 3 ).
| ROI
| Whole-brain analysis
When both patient groups were compared to HC, decreased FA in the superior medial gyrus was detected (x=−8, y=40, z=52, Z=4.54, k=77,
P<.001).
There were no significant differences between BD and UD patients.
When clinical variables (number of depressive episodes, illness duration and medication load) were added to the model, results for the two patient groups showed similar patterns (see Table S3 ). Reversed t tests (patient groups > healthy controls) did not yield any significant results in the white matter analysis. In the GM analysis, we found a cluster with increased FA in the occipital cortex in BD patients compared to HC and in the ROI analysis we found increased FA in the posterior corpus callosum in UD patients compared to HC (see Table S4 ).
| Correlation analysis
Correlation analysis showed several significant correlations between the mean FA of significant clusters and disease severity indices. Highly significant (.01 P-level, two-tailed) positive correlations were found for UD patients between mean FA in the superior medial gyrus cluster (see Table S1 ) and number of depressive episodes, total sick days due to psychiatric illness and months of paid disability leave. For BD patients, we found highly significant correlations between the mean FA in the inter- Table S1 .
| DISCUSSION
Despite a pressing need to find neurobiological markers that can help to distinguish UD and BD, DTI measures have not yet been employed on a large scale with robust results. Although visible structural changes in psychiatric and neurological diseases have not been detected using conventional neuroimaging, microstructural abnormalities of brain white matter have been discovered using DTI. [40] [41] [42] In addition, FA maps have been successfully employed to discriminate patients from controls using multivariate analyses in dementia patients, which may indicate the possibility of the clinical application of DTI measures in the future. 43, 44 To our knowledge, only three studies, with small sample sizes, have directly compared UD and BD patients regarding structural connectivity measures using DTI. We found FA reductions in a white matter cluster (MNI: 32, −22, −34), and using an ROI analysis, and also in the callosum and cingulum in BD patients compared to UD patients. These results show potential for future research into possible biomarkers for affective disorders.
The finding of FA reductions in the white matter cluster, which is located in a region where the superior longitudinal tract and the corticospinal tract cross, is consistent with a meta-analysis on BD, Furthermore, the more specific localization of our findings in the callosum and the cingulum is consistent with the results of the aforementioned meta-analysis
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: the abnormalities in the callosum were located in the frontal part (the genu of the corpus callosum) and the FA reductions in the cingulum were located in the posterior cingulate cortex (PCC). The genu of the corpus callosum is a crucial area through which commissural fibers pass. These fibers, including the forceps minor, connect the hemispheres of the prefrontal cortex, which are central to current concepts of emotional dysregulation in UD and BD. 26, 45, 46 Disturbed structural connectivity in the callosum may thus provide a structural basis for abnormal emotion processing in these areas. The FA reductions in the posterior cingulum in BD, which is known to be involved in neurocognitive functions such as attention, planning and memory, could be interpreted as a correlate of worse cognitive deficits in BD compared to UD. 47, 48 Moreover, the findings of this study are consistent with previous research directly comparing UD and BD showing no FA differences, but differences in mean diffusivity and radial diffusivity in the posterior cingulate between UD and BD 15 The FA reductions in the frontal gyri in both UD and BD compared to HC were at least partly localized in GM. The prefrontal cortex is commonly affected in both structure [49] [50] [51] and function 46, 52, 53 few results are noteworthy. We showed that the superior medial gyrus (GM) FA in UD was highly negatively correlated with disease severity scores, indicating an effect of disease on brain structure. Interestingly, this effect was only present in UD and not in BD, which might indicate a stronger association between clinical severity scores and brain alterations in UD compared to BD. Also, the corpus callosum cluster showed a negative correlation between FA and time since first depressive symptoms, which supports the hypothesis of the association between disease duration and microstructural changes in this area. It remains unclear, however, whether these abnormalities are the cause of a more severe course of illness or an effect of illness on the brain.
| Limitations
The interpretation of GM FA changes is challenging. So far, FA has only been validated to resemble disturbances in white matter integrity. Future studies need to test possible hypotheses of GM FA reduction (e.g., decreased FA as a precursor to future GM disturbances and/or decline).
As expected, BD and UD patients differed in clinical variables, with more depressive episodes and an earlier onset of disease in the BD group, which makes interpreting results more difficult, especially considering the apparent influence of disease severity on FA changes. In addition, medication differs in these two groups. Thus, the possibility cannot be excluded with certainty that the differences in FA between these groups were only a reflection of disease severity and/or medication effect and that such differences are not of any value in helping to distinguish between these disorders. When adding clinical covariates that differed between UD and BD patients (number of depressive episodes, medication index and illness duration) to the general linear model, a similar pattern of results comparing UD and BD was still found (Table S3) , indicating an effect of diagnosis and rather than a representation of clinical severity.
One of the strengths of our study is the direct comparison of the two patient groups. In addition, whereas in current literature samples were mixed and heterogeneous (depressed, manic, remitted, etc.), all our patients were experiencing a depressive episode, excluding state as a possible explanation for differences between patient groups. 
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